Clinical Trials for Rheumatoid Arthritis

Rheumatoid arthritis (RA) is an autoimmune condition in which your immune system attacks the lining of your joints, causing pain, swelling, and over time, joint damage. It is one of the most researched autoimmune conditions in the world, and clinical trials continue to produce new treatment options for people who have not responded to existing therapies -- or who cannot access them because of insurance barriers.

If you have RA and your treatment has been denied, or if your current medication has stopped working, clinical trials may offer a path worth exploring.

What Types of Trials Are Available?

RA trial research is broad and active:

Biologic trials are studying new TNF inhibitors, IL-6 inhibitors, and other targeted agents that work like -- or improve on -- existing biologics such as adalimumab (Humira) and etanercept (Enbrel). JAK inhibitor trials continue to study this class of oral medications, which work differently than biologics and may be appropriate for people who have not responded to injectable therapy. Biosimilar trials are studying whether biosimilar versions of existing drugs (which are more affordable) perform equivalently to the originator biologics. Early remission studies are exploring whether earlier, more aggressive treatment can lead to sustained remission in people who are newly diagnosed.

Search ClinicalTrials.gov for currently recruiting RA trials near you.

Am I Eligible?

Common eligibility factors for RA trials include:

- Confirmed RA diagnosis meeting established clinical criteria

- Disease activity level (many trials require moderate to severe disease)

- Prior treatment history -- including which biologics or DMARDs you have tried and whether they worked

- Specific lab markers (RF, anti-CCP antibody levels, CRP, ESR)

- No serious infections or certain other health conditions

Some trials specifically enroll people who have failed two or more biologics. Others focus on early-stage RA. The range is wide.

Your rheumatologist is the right guide here. Talk to your doctor before making any decisions about your treatment.

What If My Insurance Denied My Medication?

Biologics for RA are among the most commonly denied specialty medications. If your rheumatologist prescribed adalimumab (Humira), etanercept (Enbrel), tocilizumab (Actemra), or another biologic and your insurance said no -- usually citing step therapy requirements or formulary restrictions -- you have the right to appeal.

While your appeal proceeds, a clinical trial studying a similar or newer mechanism may be worth exploring. Many trials are specifically designed for people who are biologic-naive or who have tried and not responded to first-line therapy -- exactly the profile insurers often try to create through step therapy.

Ellen can help you understand your denial and what comes next.

Ellen can help you figure out your next step. Start with Ellen →

Frequently Asked Questions

Are clinical trials for rheumatoid arthritis free?

In most cases, yes. Trial sponsors (pharmaceutical companies, universities, or the NIH) cover the cost of the experimental treatment. You may still have costs for routine care — like doctor visits or standard tests — depending on your insurance. Always ask the trial coordinator what costs you might be responsible for before enrolling.

How do I find rheumatoid arthritis trials near me?

The best place to start is ClinicalTrials.gov, the official registry of all trials in the US. Search by condition name and filter by your location. Your specialist can also help identify trials at academic medical centers in your region.

Can I join a trial after being denied Humira or Rinvoq?

Yes, and in many cases a denial can actually make you a stronger candidate — trials often enroll patients who have not responded to or cannot access standard treatments. Talk to your doctor about whether your denial history makes you eligible for open trials studying Humira or Rinvoq or similar medications.